6F7B

Crystal structure of the human Bub1 kinase domain in complex with BAY 1816032


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.254 
  • R-Value Work: 0.198 
  • R-Value Observed: 0.201 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP InhibitorsIn VitroandIn Vivo.

Siemeister, G.Mengel, A.Fernandez-Montalvan, A.E.Bone, W.Schroder, J.Zitzmann-Kolbe, S.Briem, H.Prechtl, S.Holton, S.J.Monning, U.von Ahsen, O.Johanssen, S.Cleve, A.Putter, V.Hitchcock, M.von Nussbaum, F.Brands, M.Ziegelbauer, K.Mumberg, D.

(2019) Clin Cancer Res 25: 1404-1414

  • DOI: https://doi.org/10.1158/1078-0432.CCR-18-0628
  • Primary Citation of Related Structures:  
    6F7B

  • PubMed Abstract: 

    The catalytic function of BUB1 is required for chromosome arm resolution and positioning of the chromosomal passenger complex for resolution of spindle attachment errors and plays only a minor role in spindle assembly checkpoint activation. Here, we present the identification and preclinical pharmacologic profile of the first BUB1 kinase inhibitor with good bioavailability.


  • Organizational Affiliation

    Bayer AG, Muellerstrasse Berlin, Germany. gerhard.siemeister@bayer.com.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Mitotic checkpoint serine/threonine-protein kinase BUB1361Homo sapiensMutation(s): 0 
Gene Names: BUB1BUB1L
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for O43683 (Homo sapiens)
Explore O43683 
Go to UniProtKB:  O43683
PHAROS:  O43683
GTEx:  ENSG00000169679 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO43683
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
CVQ
Query on CVQ

Download Ideal Coordinates CCD File 
B [auth A]2-[3,5-bis(fluoranyl)-4-[[3-[5-methoxy-4-[(3-methoxypyridin-4-yl)amino]pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]ethanol
C27 H24 F2 N6 O4
QVOGVAVHOLLLAZ-UHFFFAOYSA-N
MG
Query on MG

Download Ideal Coordinates CCD File 
C [auth A]MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
SEP
Query on SEP
A
L-PEPTIDE LINKINGC3 H8 N O6 PSER
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.254 
  • R-Value Work: 0.198 
  • R-Value Observed: 0.201 
  • Space Group: P 21 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 50.497α = 90
b = 60.093β = 90
c = 124.469γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2018-12-19
    Type: Initial release
  • Version 1.1: 2019-04-24
    Changes: Data collection, Database references
  • Version 1.2: 2021-05-05
    Changes: Derived calculations